SDHAF1
Basic information
Region (hg38): 19:35995188-35996312
Links
Phenotypes
GenCC
Source:
- mitochondrial complex II deficiency, nuclear type 1 (Strong), mode of inheritance: AR
- mitochondrial complex II deficiency (Supportive), mode of inheritance: AR
- mitochondrial complex II deficiency (Moderate), mode of inheritance: AR
- Leigh syndrome (Limited), mode of inheritance: AR
- mitochondrial disease (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Mitochondrial complex II deficiency, nuclear type 2 | AR | Biochemical; Cardiovascular | Medical treatment (eg, riboflavin, ubiquinol) may be beneficial; Individuals may multisystemic, including cardiac, involvemen (which can include arrhythmias), and surveillance and early interventions may be beneficial | Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Ophthalmologic | 12112045; 16737791; 19465911; 22995659; 23322652 |
ClinVar
This is a list of variants' phenotypes submitted to
- Mitochondrial complex 2 deficiency, nuclear type 2 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SDHAF1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | 15 | ||||
missense | 30 | 32 | ||||
nonsense | 3 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 12 | |||||
Total | 1 | 3 | 41 | 17 | 2 |
Highest pathogenic variant AF is 0.00000657
Variants in SDHAF1
This is a list of pathogenic ClinVar variants found in the SDHAF1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-35995211-C-G | Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Jan 13, 2018) | ||
19-35995238-C-T | not specified | Likely benign (Dec 15, 2016) | ||
19-35995277-G-A | Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Jan 13, 2018) | ||
19-35995278-A-C | Inborn genetic diseases | Uncertain significance (Aug 13, 2023) | ||
19-35995279-G-A | Uncertain significance (Jul 05, 2022) | |||
19-35995291-G-C | Inborn genetic diseases | Uncertain significance (Aug 22, 2022) | ||
19-35995294-T-C | Uncertain significance (Nov 11, 2024) | |||
19-35995296-C-T | Mitochondrial complex 2 deficiency, nuclear type 2 | Likely pathogenic (Apr 27, 2017) | ||
19-35995302-C-T | Mitochondrial complex 2 deficiency, nuclear type 2 | Pathogenic (Sep 02, 2022) | ||
19-35995303-A-C | Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Jul 05, 2019) | ||
19-35995316-G-C | Likely benign (Feb 24, 2024) | |||
19-35995317-T-C | Inborn genetic diseases • not specified | Uncertain significance (Jun 30, 2024) | ||
19-35995317-T-G | Mitochondrial complex 2 deficiency, nuclear type 2 | Uncertain significance (-) | ||
19-35995319-C-T | Likely benign (Jul 25, 2022) | |||
19-35995320-C-T | Mitochondrial complex II deficiency, nuclear type 1 • Inborn genetic diseases | Uncertain significance (Apr 06, 2023) | ||
19-35995323-G-A | Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Apr 28, 2017) | ||
19-35995323-G-C | Inborn genetic diseases | Uncertain significance (Jun 23, 2023) | ||
19-35995332-C-T | Inborn genetic diseases | Uncertain significance (Dec 12, 2023) | ||
19-35995336-C-G | Inborn genetic diseases | Uncertain significance (Sep 18, 2024) | ||
19-35995338-G-C | Inborn genetic diseases | Uncertain significance (Jun 07, 2024) | ||
19-35995339-G-T | Inborn genetic diseases | Uncertain significance (Jun 07, 2024) | ||
19-35995340-G-A | Likely benign (Nov 22, 2022) | |||
19-35995347-A-C | Uncertain significance (Nov 05, 2024) | |||
19-35995364-G-C | Inborn genetic diseases | Likely benign (Dec 24, 2023) | ||
19-35995369-T-A | Mitochondrial complex 2 deficiency, nuclear type 2 | Likely pathogenic (Dec 19, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SDHAF1 | protein_coding | protein_coding | ENST00000378887 | 1 | 1131 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0870 | 0.577 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.379 | 49 | 57.1 | 0.859 | 0.00000286 | 681 |
Missense in Polyphen | 16 | 19.595 | 0.81653 | 223 | ||
Synonymous | 0.936 | 21 | 27.2 | 0.772 | 0.00000137 | 259 |
Loss of Function | -0.0930 | 1 | 0.905 | 1.11 | 3.87e-8 | 8 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays an essential role in the assembly of succinate dehydrogenase (SDH), an enzyme complex (also referred to as respiratory complex II) that is a component of both the tricarboxylic acid (TCA) cycle and the mitochondrial electron transport chain, and which couples the oxidation of succinate to fumarate with the reduction of ubiquinone (coenzyme Q) to ubiquinol. Promotes maturation of the iron-sulfur protein subunit SDHB of the SDH catalytic dimer, protecting it from the deleterious effects of oxidants. May act together with SDHAF3. {ECO:0000269|PubMed:19465911, ECO:0000269|PubMed:24954417}.;
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.272
- ghis
- 0.536
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.448
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sdhaf1
- Phenotype
Gene ontology
- Biological process
- mitochondrial respiratory chain complex II assembly
- Cellular component
- mitochondrion;mitochondrial matrix
- Molecular function
- protein binding